usual treatment is docetaxel as first line chemo and cabazitaxel second line.
though they are both taxane chemos so can understand why patients and oncologists might be reluctant to move onto cabazitaxel if patient has judt progressed on docetaxel. esp if the patients had side effects
Problem with ProstACT Clinical Trial, page-6
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.53 |
Change
0.335(1.75%) |
Mkt cap ! $6.513B | |||
| Open | High | Low | Value | Volume |
| $19.13 | $19.62 | $19.01 | $11.13M | 573.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 539 | $19.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.53 | 1211 | 14 |
View Market Depth
| Last trade - 14.58pm 19/08/2024 (20 minute delay) ? |
| TLX (ASX) Chart |